Cargando…
CK‐2127107 amplifies skeletal muscle response to nerve activation in humans
Introduction Three studies evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of CK‐2127107 (CK‐107), a next‐generation fast skeletal muscle troponin activator (FSTA), in healthy participants. We tested the hypothesis that CK‐107 would amplify the force‐frequency response of musc...
Autores principales: | Andrews, Jinsy A., Miller, Timothy M., Vijayakumar, Vipin, Stoltz, Randall, James, Joyce K., Meng, Lisa, Wolff, Andrew A., Malik, Fady I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681065/ https://www.ncbi.nlm.nih.gov/pubmed/29150952 http://dx.doi.org/10.1002/mus.26017 |
Ejemplares similares
-
Tirasemtiv amplifies skeletal muscle response to nerve activation in humans
por: Hansen, Richard, et al.
Publicado: (2014) -
Fast skeletal muscle troponin activator CK‐2066260 mitigates skeletal muscle weakness independently of the underlying cause
por: Cheng, Arthur J., et al.
Publicado: (2020) -
Fast skeletal muscle troponin activator CK‐2066260 increases fatigue resistance by reducing the energetic cost of muscle contraction
por: Cheng, Arthur J., et al.
Publicado: (2019) -
The Ca(2+) sensitizer CK‐2066260 increases myofibrillar Ca(2+) sensitivity and submaximal force selectively in fast skeletal muscle
por: Hwee, Darren T., et al.
Publicado: (2017) -
Ablation of Protein Kinase CK2β in Skeletal Muscle Fibers Interferes with Their Oxidative Capacity
por: Eiber, Nane, et al.
Publicado: (2017)